Pregnancy and lactation in patients with common variable immunodeficiency: a single center experience
Main Article Content
Keywords
newborn, common variable immune deficiency, pregnancy, consanguinity
Abstract
Introduction: Common variable immunodeficiency (CVID) is a primary antibody deficiency characterized by hypogammaglobulinemia and recurrent infections. Studies on the effects of CVID in pregnant patients are still needed. We aimed to investigate the effects of CVID on pregnancy outcomes and newborns.
Methods: We retrospectively evaluated 33 women with CVID and 94 pregnant women at our center. Patients were assessed based on infection rates, pregnancy complications, and use of immunoglobulin replacement therapy (IgRT) in both preterm and post-term periods. Patient data were collected from hospital databases and medical records.
Results: The mean age at first pregnancy was 24.7 (17–45) years, with an average of 2.8 pregnancies per woman. CVID was detected before pregnancy in 24.2% of cases, and 24.2% of patients initiated IgRT during pregnancy. The live birth rate was 69.1%, while early fetal loss occurred in 27.7% of pregnancies, and stillbirth in 3.2%. Infection-related complications occurred in 18% of pregnancies and 14.9% of postpartum periods. The most common infections were upper respiratory and urinary tract infections. Parenteral antibiotic treatment was required for patients who did not receive IgRT during pregnancy. Neonatal infections were observed in 6.6% of cases, and the admission rate to the neonatal intensive care unit was 5.5%.
Conclusion: Our study emphasizes that live birth and fetal loss rates in patients with CVID are comparable to those in the general population. Informing patients of the potential risks associated with consanguinity is crucial. Moreover, given the increased vulnerability of patients with CVID to infections, extra precautions are needed during pregnancy and the postpartum period.
References
2 Yazdani R, Abolhassani H, Asgardoon MH, Shaghaghi M, Modaresi M, Azizi G, et al. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders. J Investig Allergol Clin Immunol 2017; 27(4): 213-24. 10.18176/jiaci.0166
3 Ameratunga R, Allan C, Woon ST. Defining Common Variable Immunodeficiency Disorders in 2020. Immunol Allergy Clin North Am 2020; 40(3): 403-20. 20200607. 10.1016/j.iac.2020.03.001
4 Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract 2019; 7(6): 1763-70. 20190215. 10.1016/j.jaip.2019.02.004
5 Brodszki N, Frazer-Abel A, Grumach AS, Kirschfink M, Litzman J, Perez E, et al. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. J Clin Immunol 2020; 40(4): 576-91. 20200217. 10.1007/s10875-020-00754-1
6 Tam JS, Routes JM. Common variable immunodeficiency. Am J Rhinol Allergy 2013; 27(4): 260-5. 10.2500/ajra.2013.27.3899
7 Huang X, Wang L, Zhao S, Liu H, Chen S, Wu L, et al. Pregnancy Induces an Immunological Memory Characterized by Maternal Immune Alterations Through Specific Genes Methylation. Front Immunol 2021; 12: 686676. 20210607. 10.3389/fimmu.2021.686676
8 Wang J, Han T, Zhu X. Role of maternal-fetal immune tolerance in the establishment and maintenance of pregnancy. Chin Med J (Engl) 2024; 137(12): 1399-406. 20240509. 10.1097/CM9.0000000000003114
9 Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012: 985646. 20111001. 10.1155/2012/985646
10 Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63(6): 425-33. 20100329. 10.1111/j.1600-0897.2010.00836.x
11 Palmeira P, Costa-Carvalho BT, Arslanian C, Pontes GN, Nagao AT, Carneiro-Sampaio MM. Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin. Pediatr Allergy Immunol 2009; 20(6): 528-35. 20090210. 10.1111/j.1399-3038.2008.00828.x
12 Egawa M, Kanegane H, Imai K, Morio T, Miyasaka N. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy. J Matern Fetal Neonatal Med 2019; 32(18): 3092-96. 20180403. 10.1080/14767058.2018.1455824
13 Mahmood I, Tegenge MA, Golding B. Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence. Antibodies (Basel) 2020; 9(2). 20200619. 10.3390/antib9020024
14 Howson C, Kinney M, Lawn J. Born too soon: The global action report on preterm birth [Documento en internet]. Suiza: March of Dimes, PMNCH, Save the Children. World Health Organization 2012.
15 Hacettepe University Institute of Population S. Turkey Demographic and Health Survey 2018. Ankara, Turkey; 2019.
16 Hansen S, Gardulf A, Andersson E, Lindqvist M, Gustafson R. Women with primary antibody deficiencies requiring IgG replacement therapy: their perception of prenatal care during pregnancy. J Obstet Gynecol Neonatal Nurs 2004; 33(5): 604-9. 10.1177/0884217504269010
17 Sheikhbahaei S, Sherkat R, Camacho-Ordonez N, Khoshnevisan R, Kalantari A, Salehi M, et al. Pregnancy, child bearing and prevention of giving birth to the affected children in patients with primary immunodeficiency disease; a case-series. BMC Pregnancy Childbirth 2018; 18(1): 299. 20180711. 10.1186/s12884-018-1927-6
18 Mallart E, Francoise U, Driessen M, Blanche S, Lortholary O, Lefort A, et al. Pregnancy in primary immunodeficiency diseases: The PREPI study. J Allergy Clin Immunol 2023; 152(3): 760-70. 20230518. 10.1016/j.jaci.2023.05.006
19 Gundlapalli AV, Scalchunes C, Boyle M, Hill HR. Fertility, pregnancies and outcomes reported by females with common variable immune deficiency and hypogammaglobulinemia: results from an internet-based survey. J Clin Immunol 2015; 35(2): 125-34. 20150109. 10.1007/s10875-014-0123-3
20 Kralickova P, Kurecova B, Andrys C, Krcmova I, Jilek D, Vlkova M, et al. Pregnancy Outcome in Patients with Common Variable Immunodeficiency. J Clin Immunol 2015; 35(6): 531-7. 20150818. 10.1007/s10875-015-0188-7
21 Najafi K, Gholami S, Moshtagh A, Bazrgar M, Sadatian N, Abbasi G, et al. Chromosomal aberrations in pregnancy and fetal loss: Insight on the effect of consanguinity, review of 1625 cases. Mol Genet Genomic Med 2019; 7(8): e820. 20190618. 10.1002/mgg3.82
22 Al-Herz W, Al-Ahmad M, Al-Khabaz A, Husain A, Sadek A, Othman Y. The Kuwait National Primary Immunodeficiency Registry 2004-2018. Front Immunol 2019; 10: 1754. 20190724. 10.3389/fimmu.2019.01754
23 Ohuma EO, Moller AB, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet 2023; 402(10409): 1261-71. 10.1016/s0140-6736(23)00878-4
24 Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234. Obstet Gynecol 2021; 138(2): e65-e90. 10.1097/AOG.0000000000004479
25 American College of O, Gynecologists’ Committee on Practice B-G. ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol 2018; 132(5): e197-e207. 10.1097/AOG.0000000000002899
26 Harris E. Infertility Affects 1 in 6 People Globally. Jama 2023; 329(17): 1443. 10.1001/jama.2023.6251
27 Infertility Workup for the Women’s Health Specialist: ACOG Committee Opinion, Number 781. Obstet Gynecol 2019; 133(6): e377-e84. 10.1097/aog.0000000000003271
28 Ballow M. Mechanisms of immune regulation by IVIG. Curr Opin Allergy Clin Immunol 2014; 14(6): 509-15. 10.1097/ACI.0000000000000116
29 Maddur MS, Othy S, Hegde P, Vani J, Lacroix-Desmazes S, Bayry J, et al. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol 2010; 30 Suppl 1: S4-8. 10.1007/s10875-010-9394-5
30 Abdolmohammadi-Vahid S, Danaii S, Hamdi K, Jadidi-Niaragh F, Ahmadi M, Yousefi M. Novel immunotherapeutic approaches for treatment of infertility. Biomed Pharmacother 2016; 84: 1449-59. 20161031. 10.1016/j.biopha.2016.10.062
31 Parhizkar F, Motavalli-Khiavi R, Aghebati-Maleki L, Parhizkar Z, Pourakbari R, Kafil HS, et al. The Impact of New Immunological Therapeutic Strategies on Recurrent Miscarriage and Recurrent Implantation Failure. Immunol Lett 2021; 236: 20-30. 20210606. 10.1016/j.imlet.2021.05.008
32 Wiesik-Szewczyk E, Jahnz-Rozyk K. A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement. Medicine (Baltimore) 2018; 97(44): e12804. 10.1097/MD.0000000000012804
33 Wilson E, Woodd SL, Benova L. Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review. J Hum Lact 2020; 36(4): 673-86. 20200414. 10.1177/0890334420907898
